Literature DB >> 8454338

Toxicity of pneumolysin to pulmonary alveolar epithelial cells.

J B Rubins1, P G Duane, D Clawson, D Charboneau, J Young, D E Niewoehner.   

Abstract

Mortality during the first several days of pneumococcal pneumonia has not decreased appreciably over the past 30 years, despite the widespread use of antibiotics. Disruption of the alveolar epithelial barrier is likely an initial step in the pathogenesis of pneumococcal pneumonia. We report that soluble factors from Streptococcus pneumoniae can directly injure isolated rat alveolar epithelial cells. Using biochemical and immunological techniques, we identified pneumolysin as a major soluble S. pneumoniae toxin for alveolar epithelial cells. Alveolar epithelial cells at 24 or 72 h after isolation were equally sensitive to injury by purified pneumolysin. Purified pneumolysin substantially increased alveolar permeability in an isolated perfused rat lung model. Electron microscopy revealed that instilled pneumolysin caused widespread lung injury, primarily to type I alveolar epithelial cells. Pneumolysin toxicity to alveolar epithelial cells may be important in the pathogenesis of acute lung injury during pneumococcal pneumonia and may facilitate pneumococcal bacteremia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8454338      PMCID: PMC281370          DOI: 10.1128/iai.61.4.1352-1358.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  Effect of insertional inactivation of the genes encoding pneumolysin and autolysin on the virulence of Streptococcus pneumoniae type 3.

Authors:  A M Berry; J C Paton; D Hansman
Journal:  Microb Pathog       Date:  1992-02       Impact factor: 3.738

2.  Identification of rat alveolar type II epithelial cells with a tannic acid and polychrome stain.

Authors:  R J Mason; S R Walker; B A Shields; J E Henson; M C Williams
Journal:  Am Rev Respir Dis       Date:  1985-05

3.  Characterization of type II alveolar epithelial cells by flow cytometry and fluorescent markers.

Authors:  T R Rochat; J M Casale; G W Hunninghake
Journal:  J Lab Clin Med       Date:  1988-10

4.  Serum antibodies to pneumolysin in patients with pneumonia.

Authors:  K Kanclerski; S Blomquist; M Granström; R Möllby
Journal:  J Clin Microbiol       Date:  1988-01       Impact factor: 5.948

5.  Activation of human complement by the pneumococcal toxin pneumolysin.

Authors:  J C Paton; B Rowan-Kelly; A Ferrante
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

6.  Failure of intensive care unit support to influence mortality from pneumococcal bacteremia.

Authors:  E W Hook; C A Horton; D R Schaberg
Journal:  JAMA       Date:  1983-02-25       Impact factor: 56.272

7.  An improved method for isolating type II cells in high yield and purity.

Authors:  L G Dobbs; R Gonzalez; M C Williams
Journal:  Am Rev Respir Dis       Date:  1986-07

8.  Diagnosis of pneumococcal pneumonia by enzyme-linked immunosorbent assay of antibodies to pneumococcal hemolysin (pneumolysin).

Authors:  M Kalin; K Kanclerski; M Granström; R Möllby
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

9.  Pneumococcal bacteremia--no change in mortality in 30 years: analysis of 104 cases and review of the literature.

Authors:  M R Kramer; B Rudensky; I Hadas-Halperin; M Isacsohn; E Melzer
Journal:  Isr J Med Sci       Date:  1987-03

10.  Effect of proteolytic enzymes on transepithelial solute transport.

Authors:  D E Niewoehner; A A Sinha; K Rice; S Cadman; D Wangensteen
Journal:  J Appl Physiol (1985)       Date:  1986-10
View more
  33 in total

1.  Sensitivities of human monocytes and epithelial cells to pneumolysin are different.

Authors:  Robert A Hirst; Hasan Yesilkaya; Edwin Clitheroe; Andrew Rutman; Nichola Dufty; Timothy J Mitchell; Christopher O'Callaghan; Peter W Andrew
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

2.  Pneumolysin-induced complement depletion during experimental pneumococcal bacteremia.

Authors:  R B Alcantara; L C Preheim; M J Gentry-Nielsen
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

3.  A novel tumor necrosis factor-mediated mechanism of direct epithelial sodium channel activation.

Authors:  István Czikora; Abdel Alli; Hui-Fang Bao; David Kaftan; Supriya Sridhar; Hans-Jürgen Apell; Boris Gorshkov; Richard White; Astrid Zimmermann; Albrecht Wendel; Meike Pauly-Evers; Jürg Hamacher; Irène Garcia-Gabay; Bernhard Fischer; Alexander Verin; Zsolt Bagi; Jean Francois Pittet; Waheed Shabbir; Rosa Lemmens-Gruber; Trinad Chakraborty; Ahmed Lazrak; Michael A Matthay; Douglas C Eaton; Rudolf Lucas
Journal:  Am J Respir Crit Care Med       Date:  2014-09-01       Impact factor: 21.405

4.  Pneumolysin is the main inducer of cytotoxicity to brain microvascular endothelial cells caused by Streptococcus pneumoniae.

Authors:  G Zysk; B K Schneider-Wald; J H Hwang; L Bejo; K S Kim; T J Mitchell; R Hakenbeck; H P Heinz
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

5.  Neutralizing antibodies elicited by a novel detoxified pneumolysin derivative, PlyD1, provide protection against both pneumococcal infection and lung injury.

Authors:  Danielle Salha; Jason Szeto; Lisa Myers; Carol Claus; Anthony Sheung; Mei Tang; Belma Ljutic; David Hanwell; Karen Ogilvie; Marin Ming; Benjamin Messham; Germie van den Dobbelsteen; Robert Hopfer; Martina M Ochs; Scott Gallichan
Journal:  Infect Immun       Date:  2012-04-02       Impact factor: 3.441

6.  Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice.

Authors:  Y Bergeron; N Ouellet; A M Deslauriers; M Simard; M Olivier; M G Bergeron
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

7.  Characterization of a recombinant pneumolysin and its use as a protein carrier for pneumococcal type 18C conjugate vaccines.

Authors:  J Kuo; M Douglas; H K Ree; A A Lindberg
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

8.  Potential role for ESAT6 in dissemination of M. tuberculosis via human lung epithelial cells.

Authors:  Arvind G Kinhikar; Indu Verma; Dinesh Chandra; Krishna K Singh; Karin Weldingh; Peter Andersen; Tsungda Hsu; William R Jacobs; Suman Laal
Journal:  Mol Microbiol       Date:  2009-11-10       Impact factor: 3.501

9.  Identification of hydrogen peroxide as a Streptococcus pneumoniae toxin for rat alveolar epithelial cells.

Authors:  P G Duane; J B Rubins; H R Weisel; E N Janoff
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

10.  FMS-like tyrosine kinase 3 ligand treatment of mice aggravates acute lung injury in response to Streptococcus pneumoniae: role of pneumolysin.

Authors:  Christina Brumshagen; Regina Maus; Andrea Bischof; Bianca Ueberberg; Jennifer Bohling; John J Osterholzer; Abiodun D Ogunniyi; James C Paton; Tobias Welte; Ulrich A Maus
Journal:  Infect Immun       Date:  2012-09-24       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.